Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1

Virus Research

Volumn 65, Issue 1, 1999, Pages 43-55

  Yamamoto, Takako ^a,b   Nakamura, Yoshiko ^a   Kishimoto, Koji ^a   Takeuchi, Hiroaki ^b   Shirakata, Masaki ^b   Mitsuya, Toshiyuki ^a   Hirai, Kanji ^b  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b Div Virol Immunol Med Res I   (Japan)

Author keywords

Epstein Barr virus; Nuclear antigen 1; T cell lymphomas

Indexed keywords

CELL NUCLEUS ANTIGEN; CELL NUCLEUS ANTIGEN 1; COMPLEMENTARY RNA; GENE PRODUCT; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; PARAFFIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROGNOSIS; RNA PROBE; SURVIVAL RATE; T CELL LYMPHOMA; VIRUS DETECTION; VIRUS INFECTION;

ANIMALS; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL; RABBITS; RETROSPECTIVE STUDIES; RNA PROBES; RNA, ANTISENSE; RNA, VIRAL; SURVIVAL RATE; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 0032743471     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(99)00101-X     Document Type: Conference Paper

References (48)

1. Anagnostopoulos I., Hummel M., Finn T., Tiemann M., Korbjuhn P., Dimmler C., Gatter K., Dallenbach F., Parwaresch M.R., Stein H. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 80:1992;1804-1812.
2. Arrand J.R., Rymo L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J. Virol. 41:1982;376-389.
3. Boos H., Berger R., Kuklik-Roos C., Iftner T., Müller-Lantzsch N. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology. 156:1987;161-165.
4. Brooks L., Yao Q.Y., Rickinson A.B., Young L.S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66:1992;2689-2697.
5. Chen C.L., Sadler R.H., Walling D.M., Su I.J., Hsieh H.C., Raab-Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J. Virol. 67:1993;6303-6308.
6. Clerici M., Wynn T.A., Berzofsky J.A., Blatt S.P., Hendrix C.W., Sher A., Coffman R.L., Shearer G.M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:1994;768-775.
7. de Bruin P.C., Jiwa N.M., van der Valk P., Van Heerde P., Gordijn R., Ossenkoppele G.J., Walboomers J.M., Meijer C.J.L.M. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course. Histopathology. 23:1993;509-518.
8. de Bruin P.C., Jiwa M., Oudejans J.J., van der Valk P., van Heerde P., Sabourin J.C., Csanaky G., Gaulard P., Noorduyn A.L., Willemze R., Meijer C.J.L.M. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood. 83:1994;1612-1618.
9. de Bruin P.C., Jiwa N.M., Oudejans J.J., Radaszkiewicz T., Meijer C.J.L.M. Epstein-Barr virus in primary gastrointestinal T-cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype. Am. J. Pathol. 146:1995;861-867.
10. Deacon E.M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A.B., Young L.S. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177:1993;339-349.
11. Delsol G., Brousset P., Chittal S., Rigal-Huguet F. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-probes in Hodgkin's disease. Am. J. Pathol. 140:1992;247-253.
12. Fennewald S., van Santen V., Kieff E. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51:1984;411-419.
13. Fukayama M., Hayashi Y., Iwasaki Y., Chong J., Ooba T., Takizawa T., Koike M., Mizutani S., Miyaki M., Hirai K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest. 71:1994;73-81.
14. Gilligan K., Rajadurai P., Resnick L., Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA. 87:1990;8790-8794.
15. Grässer F.A., Murray P.G., Kremmer E., Klein K., Remberger K., Feiden W., Reynolds G., Niedebitek G., Young L.S., Müller-Lantzsch N. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood. 84:1994;3792-3798.
16. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 335:1990;128-130.
17. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Müller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA. 88:1991;4766-4770.
18. Hironaka T., Nagasaki M., Morikawa S., Hirai K. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J. Virol. Methods. 44:1993;141-154.
19. Hirota S., Ito A., Morii E., Wanaka A., Tohyama M., Kitamura Y., Nomura S. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization. Brain Res. Mol. Brain Res. 15:1992;47-54.
20. Ho F.C., Srivastava G., Loke S.L., Fu K.H., Leung B.P., Liang R., Choy D. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell. Hematol. Oncol. 8:1990;271-281.
21. Hojo I., Takanashi M., Hirai K., Mori S. Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues. Arch. Virol. 140:1995;1419-1426.
22. Howe J.G., Steitz J.A. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc. Natl. Acad. Sci. USA. 83:1986;9006-9010.
23. Jones J.F., Shurin S., Abramowsky C., Tubbs R.R., Sciotto C.G., Wahl R., Sands J., Gottman D., Katz B.Z., Sklar J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 318:1988;733-741.
24. Kanavaros P., Lescs M.C., Briere J., Divine M., Galateau F., Joab I., Bosq J., Farcet J.P., Reyes F., Gaulard P. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 81:1993;2688-2695.
25. Khan G., Norton A.J., Slavin G. Epstein-Barr virus in angioimmunoblastic T-cell lymphomas. Histopathology. 22:1993;145-149.
26. Kikuta H., Taguchi Y., Tomizawa K., Kojima K., Kawamura N., Ishizaka A., Sakiyama Y., Matsumoto S., Imai S., Kinoshita T., Koizumi S., Osato T., Kobayashi I., Hamada I., Hirai K. Epstein-Barr virus genome-positive T-lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 333:1988;455-457.
27. Kikuta H., Sakiyama Y., Matsumoto S., Ohishi T., Nakano T., Nagashima T., Oka T., Hironaka T., Hirai K. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 82:1993;3259-3264.
28. Kobayashi R., Takeuchi H., Sasaki M., Hasegawa M., Hirai K. Detection of Epstein-Barr virus infection in the epitherial cells and lymphocytes of non-neoplastic tonsils by in situ hybridization and in situ PCR. Arch. Virol. 143:1998;803-813.
29. Korbjuhn P., Anagnostopoulos I., Hummel M., Tiemann M., Dallenbach F., Parwaresch M.R., Stein H. Frequent latent Epstein-Barr virus infection of neoplastic T-cells and bystander B-cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood. 82:1993;217-223.
30. Minarovits J., Hu L.F., Imai S., Harabuchi Y., Kataura A., Minarovits-Kormuta S., Osato T., Klein G. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T-cell lymphomas. J. Gen. Virol. 75:1994;77-84.
31. Muso E., Fujiwara H., Yoshida H., Hosokawa R., Yashiro M., Hongo Y., Matsumia T., Yamabe H., Kikuta H., Hironaka T., Hirai K., Kawai C. Epstein-Barr virus genome-positive tubulointerstital nephritis associated with Kawasaki disease-like coronary aneurysms. Clin. Nephrol. 40:1993;7-15.
32. Nakagomi H., Dolcetti R., Bejarano M.T., Pisa P., Kiessling R., Masucci M.G. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int. J. Cancer. 57:1994;240-244.
33. Ohshima K., Suzumiya J., Tashiro K., Mukai Y., Tanaka T., Kato A., Kikuchi M. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Am. J. Hematol. 52:1996;21-28.
34. Pallesen G., Hamilton-Dutoit S.J., Rowe M., Young L.S. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet. 337:1991;320-322.
35. Pan L., Diss T.C., Peng H., Lu Q., Wotherspoon A.C., Thomas J.A., Isaacson P.G. Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL). J. Pathol. 170:1993;137-143.
36. Pathmanathan R., Prasad U., Chandrika G., Sadler R., Flynn K., Raab-Traub N. Undifferentiated, non-keratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am. J. Pathol. 146:1995;1355-1367.
37. Raab-Traub N., Flynn K., Pearson G., Huang A., Levine P., Lanier A., Pagano J.S. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int. J. Cancer. 39:1987;25-29.
38. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roisman B., Straus S.E. Field's Virology. 3rd ed:1996;2397-2447 Lippincott-Raven, New York.
39. Rosenberg S.A., Beard C.W., Brown B.W. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer. 49:1982;2112-2135.
40. Sabourin J.-C., Kanavaros P., Briere J., Lescs M.-C., Petrella T., Zafrani E.S., Gaulard P.H. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in non-immunocompromised patients. Am. J. Surg. Pathol. 17:1993;995-1002.
41. Sambrook J., Fritsch F., Maniatis T. Molecular Cloning. A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
42. Shibata D., Tokunaga M., Uemura Y., Sato E., Tanaka S., Weiss L.M. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol. 139:1991;469-474.
43. Takeuchi H., Kobayashi R., Hasegawa M., Hirai K. Detection of Epstein-Barr virus infection in the epithelial cells and lymphocytes of non-neoplastic tonsils by in situ hybridization and in situ PCR. Arch. Virol. 142:1997;1743-1756.
44. Tokunaga M., Land C.E., Uemura Y., Tokudome T., Tanaka S., Sato E. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 143:1993;1250-1254.
45. Tokunaga M., Imai S., Uemura Y., Tokudome T., Osato T., Sato E. Epstein-Barr virus in adult T-cell leukemia/ lymphoma. Am. J. Pathol. 143:1993;1263-1269.
46. Wang F., Gregory C.D., Rowe M., Rickinson A.B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA. 84:1987;3452-3456.
47. Weiss L.M., Gaffey M.J., Chen Y.Y., Frierson H.F.J.r. Frequency of Epstein-Barr viral DNA in 'Western' sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am. Surg. Pathol. 15:1992;156-162.
48. Weiss L.M., Jaffe E.S., Liu X.F., Chen Y.Y., Shibata D., Medeiros L.J. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 79:1992;1789-1795.